Skip to main content

A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

Gene Transfer Clinical Study in Crigler-Najjar Syndrome

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Gene Transfer Clinical Study in Crigler-Najjar Syndrome

Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

Vitamin D to Improve Outcomes by Leveraging Early Treatment

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Vitamin D to Improve Outcomes by Leveraging Early Treatment

Metoclopramide for Post Traumatic Headache

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Metoclopramide for Post Traumatic Headache

0.25% Bupivacaine Versus a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about 0.25% Bupivacaine Versus a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka

A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation

Safety and Efficacy of Apixaban in Severe Renal Impairment

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety and Efficacy of Apixaban in Severe Renal Impairment

Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 103
  • Page 104
  • Page 105
  • Page 106
  • Page 107
  • Page 108
  • Page 109
  • Page 110
  • Page 111
  • …
  • Next page Next
  • Last page Last
Subscribe to